Genomictree, Inc. is an enterprise based in South Korea. Its main office is in Daejeon. The company operates in the Research and Development in Nanotechnology sector. It was established on October 15, 2000. Genomictree, Inc. currently employs 79 (2024) people. The latest financial highlights indicate a net sales revenue increase of 90.82% in Q3C2025. Its’ total assets recorded a negative growth of 7.22%. In 2025, Genomictree, Inc.’s net profit margin increased by 317.71%.

Headquarters
44-6, Techno 10-Ro, Yuseong-Gu, Daejeon
Daejeon; Daejeon;

Contact Details: Purchase the Genomictree, Inc. report to view the information.

Website: http://genomictree.com/ko

Basic Information

Total Employees:

Purchase the Genomictree, Inc. report to view the information.

Outstanding Shares:

Purchase the Genomictree, Inc. report to view the information.

Registered Capital:

Purchase the Genomictree, Inc. report to view the information.

Financial Auditors:

Purchase the Genomictree, Inc. report to view the information.

Incorporation Date:

October 15, 2000

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Ownership Details

Purchase this report to view the information.

17.7%

Purchase this report to view the information.

8.4%

Purchase this report to view the information.

6.3%

Subsidiaries

Promis Diagnostics Inc

Company Performance

Financial values in the chart are available after Genomictree, Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

90.82%▲

Total Operating Revenue

47.33%▲

Operating Profit

20.2%▲

EBITDA

24.39%▲

Net Profit/Loss for the Period

17.15%▲

Total Assets

-7.22%▼

Total Equity

-6.74%▼

Operating Profit Margin

424.71%▲

Net Profit Margin

317.71%▲

Return on Equity (ROE)

0.77%▲

Debt / Equity

0.36%▲

Quick Ratio

-2.15%▼

Cash Ratio

-1.09%▼

Genomictree, Inc. (South Korea)

Similar companies